eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | huntington disease |
| Symptom | C0008489|chorea |
| Sentences | 17 |
| PubMedID- 24908519 | huntington's disease presenting with chorea of the ears. |
| PubMedID- 23674480 | Pharmacological treatment of chorea in huntington's disease-good clinical practice versus evidence-based guideline. |
| PubMedID- 25733999 | Dbs has recently been employed for relief of symptoms of chorea in patients with huntington's disease and chac. |
| PubMedID- 20135628 | The classical vmat2 inhibitor, tetrabenazine, has long been used for the treatment of chorea associated with huntington's disease in the united kingdom, canada, and australia, and recently approved in the united states. |
| PubMedID- 24255799 | Food and drug administration in 2008 for the treatment of chorea associated with huntington's disease (hd), there is a paucity of data on its long-term efficacy and safety. |
| PubMedID- 23280482 | Tetrabenazine is effective in the treatment of the chorea associated with huntington disease and other hyperkinetic movement disorders. |
| PubMedID- 22133328 | Tetrabenazine: for chorea associated with huntington's disease. |
| PubMedID- 23439575 | Background: tetrabenazine is a monoamine depleter with a well-documented effect against chorea associated with huntington disease (hd). |
| PubMedID- 25689146 | A randomized, placebo-controlled trial of afq056 for the treatment of chorea in huntington's disease. |
| PubMedID- 21487088 | Tetrabenazine is a central monoamine-depleting agent approved by the food and drug administration for chorea associated with huntington's disease. |
| PubMedID- 21396745 | In summary, (+)-1, (+)-2, and their derivatives warrant further studies in order to develop more potent and safer drugs for the treatment of chorea associated with huntington's disease and other hyperkinetic disorders. |
| PubMedID- 24457996 | During solution formulation study of tetrabenazine (tbz), a dopamine depleting agent, used in chorea associated with huntington's disease and symptomatic treatment of hyperkinetic movement disorder it was observed a strong discoloration upon storage. |
| PubMedID- 25156927 | chorea associated with huntington's disease: to treat or not to treat. |
| PubMedID- 20235241 | Highly concise asymmetric total syntheses of (+)-tetrabenazine (1), a drug for the treatment of chorea associated with huntington's disease, and of (+)-alpha-dihydrotetrabenazine (2), an active metabolite of 1, have been accomplished. |
| PubMedID- 22139861 | Tetrabenazine is an efficacious treatment for chorea associated with huntington disease (hd). |
| PubMedID- 23585991 | Beneficial effects of fluvoxamine for chorea in a patient with huntington's disease: a case report. |
| PubMedID- 21975581 | It is generally believed that treatments are available to manage chorea in huntington's disease (hd). |
Page: 1